Dosing regimen

Details Dosing regimen Dosing regimen

A - Human Necessities

61

K

A61K 38/10 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2726603

The present invention provides a method for treating hematological disorders such as anemia and thrombocytopema, whereby a TPO mimetic peptide compound is administered using a specified dosing regimen. The dosing regimen involves the administration of the TPO mimetic peptide compound within a specified time frame surrounding administration of a chemotherapeutic agent. The dosing regimen also involves monitoring subject response in order to determine future course of treatment.

La présente invention porte sur un procédé pour traiter des troubles hématologiques tels que l'anémie et la thrombocytopénie, par lesquels un composé peptidique mimétique TPO est administré à l'aide dun schéma posologique spécifié. Le schéma posologique entraîne l'administration du composé peptidique mimétique TPO dans un intervalle de temps spécifié encadrant l'administration d'un agent chimiothérapique. Le schéma posologique entraîne également la surveillance de la réponse du sujet afin de déterminer un traitement futur.

Affiliated with

Also associated with

Rating

Dosing regimen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosing regimen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosing regimen will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1584871